• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Update: Influenza Activity - United States, September 30, 2018-February 2, 2019

tetano

Editor, Senior Moderator
MMWR Morb Mortal Wkly Rep. 2019 Feb 15;68(6):125-134. doi: 10.15585/mmwr.mm6806a1.
[h=1]Update: Influenza Activity - United States, September 30, 2018-February 2, 2019.[/h] Blanton L[SUP]1[/SUP], Dugan VG[SUP]1[/SUP], Abd Elal AI[SUP]1[/SUP], Alabi N[SUP]1[/SUP], Barnes J[SUP]1[/SUP], Brammer L[SUP]1[/SUP], Budd AP[SUP]1[/SUP], Burns E[SUP]1[/SUP], Cummings CN[SUP]1[/SUP], Garg S[SUP]1[/SUP], Garten R[SUP]1[/SUP], Gubareva L[SUP]1[/SUP], Kniss K[SUP]1[/SUP], Kramer N[SUP]1[/SUP], O'Halloran A[SUP]1[/SUP], Reed C[SUP]1[/SUP], Rolfes M[SUP]1[/SUP], Sessions W[SUP]1[/SUP], Taylor C[SUP]1[/SUP], Xu X[SUP]1[/SUP], Fry AM[SUP]1[/SUP], Wentworth DE[SUP]1[/SUP], Katz J[SUP]1[/SUP], Jernigan D[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] CDC collects, compiles, and analyzes data on influenza activity and viruses in the United States. During September 30, 2018-February 2, 2019,* influenza activity[SUP]?[/SUP] in the United States was low during October and November, increased in late December, and remained elevated through early February. As of February 2, 2019, this has been a low-severity influenza season (1), with a lower percentage of outpatient visits for influenza-like illness (ILI), lower rates of hospitalization, and fewer deaths attributed to pneumonia and influenza, compared with recent seasons. Influenza-associated hospitalization rates among children are similar to those observed in influenza A(H1N1)pdm09 predominant seasons; 28 influenza-associated pediatric deaths occurring during the 2018-19 season have been reported to CDC. Whereas influenza A(H1N1)pdm09 viruses predominated in most areas of the country, influenza A(H3N2) viruses have predominated in the southeastern United States, and in recent weeks accounted for a growing proportion of influenza viruses detected in several other regions. Small numbers of influenza B viruses (<3% of all influenza-positive tests performed by public health laboratories) also were reported. The majority of the influenza viruses characterized antigenically are similar to the cell culture-propagated reference viruses representing the 2018-19 Northern Hemisphere influenza vaccine viruses. Health care providers should continue to offer and encourage vaccination to all unvaccinated persons aged ≥6 months as long as influenza viruses are circulating. Finally, regardless of vaccination status, it is important that persons with confirmed or suspected influenza who have severe, complicated, or progressive illness; who require hospitalization; or who are at high risk for influenza complications be treated with antiviral medications.


PMID: 30763296 DOI: 10.15585/mmwr.mm6806a1
[Indexed for MEDLINE] Free full text
 
Back
Top Bottom